|
JP2001523695A
(ja)
*
|
1997-11-24 |
2001-11-27 |
ザ スクリップス リサーチ インスティテュート |
ギャップ結合連絡の阻害剤
|
|
US6858649B1
(en)
*
|
1998-04-30 |
2005-02-22 |
The Scripps Research Institute |
Selective potentiation of serotonin receptor subtypes
|
|
GB9926833D0
(en)
*
|
1999-11-15 |
2000-01-12 |
Univ Sunderland |
Compositions
|
|
WO2002062963A2
(en)
*
|
2001-02-08 |
2002-08-15 |
Nps Pharmaceuticals, Inc. |
Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same
|
|
US20050154064A1
(en)
*
|
2001-03-27 |
2005-07-14 |
The Regents Of The University Of California |
Dietary and other compositions, compounds, and methods for reducing body fat, controlling appetite, and modulating fatty acid metabolism
|
|
US20050054730A1
(en)
*
|
2001-03-27 |
2005-03-10 |
The Regents Of The University Of California |
Compounds, compositions and treatment of oleoylethanolamide-like modulators of PPARalpha
|
|
AU2002338329B2
(en)
|
2001-03-27 |
2006-09-07 |
The Regents Of The University Of California |
Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism
|
|
US7351874B2
(en)
*
|
2001-07-31 |
2008-04-01 |
The Scripps Research Institute |
Mouse model for fatty acid amide-related neurobehaviors
|
|
ES2186576B1
(es)
*
|
2001-10-11 |
2004-09-16 |
Universitat De Les Illes Balears |
Acido 2-hidroxioleico para utilizar como medicamento.
|
|
US20040063726A1
(en)
*
|
2002-02-08 |
2004-04-01 |
Artman Linda D |
Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same
|
|
EP1558591B1
(en)
*
|
2002-10-07 |
2014-05-07 |
The Regents of The University of California |
Modulation of anxiety through blockade of anandamide hydrolysis
|
|
US7765162B2
(en)
*
|
2002-10-07 |
2010-07-27 |
Mastercard International Incorporated |
Method and system for conducting off-line and on-line pre-authorized payment transactions
|
|
PL2937341T3
(pl)
|
2004-12-30 |
2017-11-30 |
Janssen Pharmaceutica N.V. |
Pochodne fenyloamidowe kwasu 4-(benzylo)-piperazyno-1-karboksylowego oraz związki powiązane, jako modulatory hydrolazy amidu kwasu tłuszczowego (FAAH) do leczenia lęku, bólu i innych schorzeń
|
|
US20090082435A1
(en)
*
|
2005-04-28 |
2009-03-26 |
The Regents Of The University Of California |
Methods, Compositions, And Compounds For Modulation Of Monoacylglycerol Lipase, Pain, And Stress-Related Disorders
|
|
PE20070099A1
(es)
|
2005-06-30 |
2007-02-06 |
Janssen Pharmaceutica Nv |
N-heteroarilpiperazinil ureas como moduladores de la amida hidrolasa del acido graso
|
|
US20090111778A1
(en)
*
|
2005-11-18 |
2009-04-30 |
Richard Apodaca |
2-Keto-Oxazoles as Modulators of Fatty Acid Amide Hydrolase
|
|
WO2007098142A2
(en)
|
2006-02-17 |
2007-08-30 |
The Scripps Research Institute |
Oxazole ketones as modulators of fatty acid amide hydrolase
|
|
US20100292266A1
(en)
*
|
2006-05-26 |
2010-11-18 |
Richard Apodaca |
Oxazolyl Piperidine Modulators of Fatty Acid Amide Hydrolase
|
|
WO2008030752A2
(en)
*
|
2006-09-07 |
2008-03-13 |
N.V. Organon |
Methods for determining effective doses of fatty acid amide hydrolase inhibitors in vivo
|
|
JO3598B1
(ar)
|
2006-10-10 |
2020-07-05 |
Infinity Discovery Inc |
الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
|
|
WO2008063714A1
(en)
*
|
2006-11-20 |
2008-05-29 |
N.V. Organon |
Metabolically-stabilized inhibitors of fatty acid amide hydrolase
|
|
PE20091838A1
(es)
*
|
2008-04-09 |
2009-12-18 |
Infinity Pharmaceuticals Inc |
Inhibidores de amida hidrolasa de acido graso
|
|
ES2342997B1
(es)
*
|
2008-12-09 |
2011-06-06 |
Universitat De Les Illes Balears |
Alpha derivados de acidos grasos cis-monoinsaturados para ser usados como medicamento.
|
|
AU2010234449A1
(en)
|
2009-04-07 |
2011-11-03 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
|
JP2012523424A
(ja)
|
2009-04-07 |
2012-10-04 |
インフイニトイ プハルマセウトイカルス インコーポレイテッド |
脂肪酸アミドヒドロラーゼの阻害薬
|
|
US9062116B2
(en)
|
2009-04-23 |
2015-06-23 |
Infinity Pharmaceuticals, Inc. |
Anti-fatty acid amide hydrolase-2 antibodies and uses thereof
|
|
US8927551B2
(en)
*
|
2009-05-18 |
2015-01-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
|
US9149465B2
(en)
*
|
2009-05-18 |
2015-10-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
|
US8765735B2
(en)
*
|
2009-05-18 |
2014-07-01 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
|
US20120225097A1
(en)
|
2009-11-12 |
2012-09-06 |
Hawryluk Natalie A |
Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah)
|
|
MX336742B
(es)
*
|
2010-02-03 |
2016-01-29 |
Infinity Pharmaceuticals Inc |
Inhibidores de amida hidrolasa de acido graso.
|
|
UA108233C2
(uk)
|
2010-05-03 |
2015-04-10 |
|
Модулятори активності гідролази амідів жирних кислот
|
|
ES2893100T3
(es)
|
2015-10-12 |
2022-02-08 |
Advanced Cell Diagnostics Inc |
Detección in situ de variantes de nucleótidos en muestras con un elevado nivel de ruido, y composiciones y métodos relacionados con ésta
|
|
WO2021097069A1
(en)
*
|
2019-11-12 |
2021-05-20 |
The Trustees Of The University Of Pennsylvania |
Oleic acid derivatives as treatments for friedreich ataxia and inhibitors of ferroptosis
|
|
CN111004125B
(zh)
*
|
2019-12-24 |
2022-11-22 |
东华理工大学 |
一种缩醛或缩酮化合物的制备方法
|
|
WO2021152201A2
(es)
|
2020-01-29 |
2021-08-05 |
Universitat De Les Illes Balears |
Metabolitos de ácidos grasos alfa-hidroxilados, usos médicos de los mismos y uso como biomarcadores
|